Compare · BIB vs DWSH
BIB vs DWSH
Side-by-side comparison of ProShares Ultra Nasdaq Biotechnology (BIB) and AdvisorShares Dorsey Wright Short ETF (DWSH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIB and DWSH operate in n/a (n/a), so they compete in similar markets.
ProShares Ultra Nasdaq Biotechnology
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
AdvisorShares Dorsey Wright Short ETF
The investment seeks capital appreciation through short selling securities. Dorsey, Wright & Associates, LLC (the "Sub-Advisor"), the sub-advisor to the fund, seeks to achieve the fund's investment objective by obtaining short exposure to investment returns of the broad U.S. large-capitalization equity market by engaging in short sales of U.S.-traded equity securities and exchange-traded funds ("ETFs"). Under normal circumstances, it invests at least 80% of its net assets (plus any borrowings for investment purposes) in investments that create or result in short exposure to U.S. equity securities.